// App-Quantinova.ai

OP0134 (2021) : NOVEL INTERFERON GENE EXPRESSION SCORES PREDICT REFRACTORY SEVERE CUTANEOUS DISEASE FOLLOWING RITUXIMAB THERAPY IN SLE

Researchers

Presenter

  • L. M. Carter

Principal Investigators

  • A. Alase

  • Z. Wigston

  • A. Psarras

  • A. Burska

  • M. Y. MD Yusof

  • E. Hensor

  • J. Reynolds

  • M. Wittmann

  • I. N. Bruce

  • E. Vital

Medical Centers

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • University of Birmingham, Institute of Inflammation and Ageing, Birmingham, UK

  • School of Biological Sciences The University of Manchester, Division of Musculoskeletal and Dermatological Sciences, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Interferon

  • Rituximab

  • IFN-lambda

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Genzyme and Sanofi

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved